lobbying_activities: 2968284
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2968284 | 7ad9f799-4645-49e8-a690-b76ec301294c | Q1 | BURRELL INTERNATIONAL GROUP LLC | 401103483 | ACER THERAPEUTICS | 2023 | first_quarter | PHA | COVID-19 therapeutics and Medical Countermeasures, Rare Disease, and Re-purposed drugs; Defense Appropriations for MCM Development | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2023-04-19T11:30:07-04:00 |